Challenges facing British oncology
Challenges facing British oncology
ESTRO 2010 Highlights
Advances in the treatment of rectal cancer
Conatumumab or AMG 479 as treatment for pancreatic cancer
Roundup of the 2010 ASCO conference
FOLFIRI plus panitumumab can lead to an increased PFS in colorectal cancer patients
Addition of panitumumab can lead to an increased survival in colorectal cancer patients
The work of Europacolon and possibilities for the future
The use of radiotherapy to treat rectal cancer and advances in surgical techniques
Individualisation and personalisation of colorectal cancer treatments
Advances in TME surgery
Progress made by the Dutch Colorectal Cancer Group and key issues emerging from the 2010 EMCCC conference